TSX:DNTL - Post Discussion
Post by
retiredcf on Nov 22, 2022 8:49am
BMO
In response to its commencement of a strategic review process, BMO’s Stephen MacLeod raised his Dentalcorp Holdings Ltd. target by $1 to $14 with an “outperform” rating. The average is $14.89.
“We view the strategic review process positively, as it provides a catalyst to potentially close the valuation gap vs. peers,” he said. “The stock is down 51 per cent year-to-date and trades at an unjustified steep discount to the peer group average. While there is a range of potential outcomes, we believe that a takeout is the most likely to realize full value for shareholders. Absent a transaction materializing, we continue to appreciate the recurring and essential characteristics of the dental market, and believe dentalcorp is well-positioned to drive double-digit revenue and EBITDA growth.”
Be the first to comment on this post